SANARA MEDTECH INC (SMTI:NASDAQ)
$19.8 -0.82 (-3.9767%)
Analysed SANARA MEDTECH INC (SMTI:NASDAQ) News Sources
How The Sanara MedTech (SMTI) Story Is Shifting With New Targets And Growth Assumptions
20-04-2026
yahoo.com
Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026
14-04-2026
yahoo.com
Sanara MedTech Inc. Q4 2025 Earnings Call Summary
25-03-2026
moby.co
Sanara MedTech Inc (SMTI) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
24-03-2026
yahoo.com
Sanara MedTech Q4 Earnings Call Highlights
24-03-2026
marketbeat.com
Sanara MedTech Inc. (SMTI) Q4 Earnings Miss Estimates
24-03-2026
yahoo.com
Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance
24-03-2026
yahoo.com
Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds
11-03-2026
yahoo.com
Evolus, Inc. (EOLS) Matches Q4 Earnings Estimates
03-03-2026
yahoo.com
Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
03-03-2026
yahoo.com
What is the current price of SANARA MEDTECH INC (SMTI:NASDAQ)?
The current price of SANARA MEDTECH INC (SMTI:NASDAQ) is $19.8.
SANARA MEDTECH INC (SMTI:NASDAQ) absolute price change since previous trading day?
The absolute price change of SANARA MEDTECH INC (SMTI:NASDAQ) since the previous trading day is $-0.82.
SANARA MEDTECH INC (SMTI:NASDAQ) percentage price change since previous trading day?
The percentage price change of SANARA MEDTECH INC (SMTI:NASDAQ) since the previous trading day is -3.9767%.
What is the most recent average sentiment score for SANARA MEDTECH INC (SMTI:NASDAQ)?
The most recent average sentiment score for SANARA MEDTECH INC (SMTI:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for SANARA MEDTECH INC (SMTI:NASDAQ)?
The most recent sentiment for SANARA MEDTECH INC (SMTI:NASDAQ) is .
SEC-8K** Filing Available For SANARA MEDTECH INC (SMTI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.